Previously, the inflammatory biomarkers (IL-6, IL-8, IL-10 and ratio of IL-6 to IL-10), patients’ characteristics (age) and chest CT images (consolidation, emphysema and residual healthy lung parenchyma) have been reported to predict the prognosis of COVID-19 patients [8, 36]. This evidence concerns the gene IL6 and COVID-19.